Progress in Lymphangiogenesis and Lymphatic Metastasis of Thyroid Carcinoma

Xu LI; Yan ZHANG

doi:10.3881/j.issn.1000-503X.15694

PDF(819 KB)

Acta Academiae Medicinae Sinicae ›› 2024, Vol. 46 ›› Issue (3) : 409-413. DOI: 10.3881/j.issn.1000-503X.15694

Review Articles

Progress in Lymphangiogenesis and Lymphatic Metastasis of Thyroid Carcinoma

Xu LI ¹^,² ,
Yan ZHANG ¹^,²

Author information +

History +

Abstract

thyroid carcinoma is a common endocrine malignancy,with most cases being indolent.lymphatic metastasis as a representative metastasis type defines the clinical stage and prognosis of thyroid carcinoma.the mechanism of lymphatic metastasis in malignancies has been a research hotspot for years,and certain progress being achieved.this article reviews the molecular markers of lymphatic vessels and their application in diagnosis and treatment of neoplasms,the mechanism and role of lymphangiogenesis in lymphatic metastasis,the tracing methods for sentinel lymph nodes by lymphatic drainage,and the use of ultrasound in cervical lymph node metastasis of thyroid carcinoma.Especially,This paper details the application of conventional ultrasound,transvenous contrast-enhanced ultrasound,and trans-lymphatic contrast-enhanced ultrasound in cervical lymph node metastasis of thyroid carcinoma。

Key words

thyroid carcinoma / lymphatic metastasis / contrast-enhanced ultrasound

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Xu LI , Yan ZHANG. Progress in Lymphangiogenesis and Lymphatic Metastasis of Thyroid Carcinoma[J]. Acta Academiae Medicinae Sinicae. 2024, 46(3): 409-413 https://doi.org/10.3881/j.issn.1000-503X.15694

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.DOI:10.3322/caac.21660. Cited in this article [1]

[2]	中国医疗保健国际交流促进会甲状腺疾病防治分会, 中华预防医学会甲状腺疾病防治专业委员会, 中国人体健康科技促进会甲状腺肿瘤专业委员会. 甲状腺癌手术中淋巴结示踪技术规范应用专家共识[J]. 中华医学杂志, 2022, 102(48):3836-3841.DOI:10.3760/cma.j.cn112137-20221018-02165. Cited in this article [3]

[3]	中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版)[J]. 中国实用外科杂志, 2017, 37(9):985-991.DOI:10.19538/j.cjps.issn1005-2208.2017.09.13. Cited in this article [1]

[4]

Haugen

, Alexander

, Bible

, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.DOI:10.1089/thy.2015.0020.

Cited in this article [1]

[5]	郑玉平, 陈奎生. 肿瘤相关微淋巴管内皮细胞的研究进展[J]. 河南大学学报(医学版), 2015, 34(3):220-225.DOI:10.15991/j.cnki.41-1361/r.2015.03.024. Cited in this article [1]

[6]	Choi Y, Park KJ, Ryu S, et al. Papillary thyroid carcinoma involving cervical neck lymph nodes:correlations with lymphangiogenesis and ultrasound features[J]. Endocr J, 2012, 59(10):941-948.DOI:10.1507/endocrj.ej12-0178. Cited in this article [1]

[7]	张熔熔. 消化道神经内分泌癌中淋巴管密度与淋巴结转移的关系[J]. 中华内分泌外科杂志, 2013, 7(3):212-214.DOI:10.3760/cma.j.issn.1674-6090.2013.03.010. Cited in this article [1]

[8]	吴玉梅, 李力. 肿瘤淋巴管生成与淋巴转移[J]. 医学分子生物学杂志, 2007, 4(5):465-468.DOI:10.3870/j.issn.1672-8009.2007.05.022. Cited in this article [1]

[9]	赵迎春, 李勇, 桑果. 淋巴管与微血管密度在乳腺癌患者预后中的意义[J]. 中华内分泌外科杂志, 2013, 7(5):371-375.DOI:10.3760/cma.j.issn.1674-6090.2013.05.006. Cited in this article [1]

[10]	许晨. 瘤内外淋巴管形成与甲状腺乳头状癌临床、病理特点的关系[D]. 天津: 天津医科大学, 2007.DOI:10.7666/d.y1127746. Cited in this article [2]

[11]	Pereira F, Pereira SS, Mesquita M, et al. Lymph node metastases in papillary and medullary thyroid carcinoma are independent of intratumoral lymphatic vessel density[J]. Eur Thyroid J, 2017, 6(2):57-64.DOI:10.1159/000457794. Cited in this article [2]

[12]	de la Torre NG, Buley I, Wass JA, et al. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions:relationship to type and tumour behaviour[J]. Endocr Relat Cancer, 2006, 13(3):931-944.DOI:10.1677/erc.1.01210. Cited in this article [1]

[13]	Hakala T, Sand J, Kellokumpu-Lehtinen PL, et al. Recurrent thyroid cancers have more peritumoural lymphatic vasculature than nonrecurrent thyroid cancers[J]. Eur J Clin Invest, 2014, 44(9):825-832.DOI:10.1111/eci.12301. Cited in this article [1]

[14]	Garcia EA, Simões K, Wakamatsu A, et al. Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions[J]. Endocr Pathol, 2010, 21(2):101-107.DOI:10.1007/s12022-010-9116-9. Cited in this article [1]

[15]	Fujimoto N, Dieterich LC. Mechanisms and clinical significance of tumor lymphatic invasion[J]. Cells, 2021, 10(10):2585.DOI:10.3390/cells10102585. Cited in this article [2]

[16]

Wei

, Yu

, Niu

, et al. Combination of lymphatic and intravenous contrast-Enhanced ultrasound for evaluation of cervical lymph node metastasis from papillary thyroid carcinoma:a preliminary study[J]. Ultrasound Med Biol, 2021, 47(2):252-260.DOI:10.1016/j.ultrasmedbio.2020.10.003.

Cited in this article [2]

[17]	Karaman S, Detmar M. Mechanisms of lymphatic metastasis[J]. J Clin Invest, 2014, 124(3):922-928.DOI:10.1172/JCI71606. Cited in this article [1]

[18]	Munn LL, Padera TP. Imaging the lymphatic system[J]. Microvasc Res, 2014, 96:55-63.DOI:10.1016/j.mvr.2014.06.006. Cited in this article [1]

[19]	王永胜, 吴炅, 刘红. 乳腺癌前哨淋巴结活检规范化操作指南(2022精要版)[J]. 中国肿瘤临床, 2022, 49(22):1136-1142.DOI:10.12354/j.issn.1000-8179.2022.20221052. Cited in this article [1]

[20]	Fang F, Gong Y, Liao L, et al. Value of contrast-enhanced ultrasound for evaluation of cervical lymph node metastasis in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2022, 13:812475.DOI:10.3389/fendo.2022.812475. Cited in this article [2]

[21]

Xiang

, Hong

, Zhang

, et al. Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients:diagnosis value and enhancement patterns of malignant lymph nodes[J]. Eur Radiol, 2014, 24(10):2513-2519.DOI:10.1007/s00330-014-3288-5.

Cited in this article [2]

[22]	Ye F, Gong Y, Tang K, et al. Contrast-enhanced ultrasound characteristics of preoperative central cervical lymph node metastasis in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2022, 13:941905.DOI:10.3389/fendo.2022.941905. Cited in this article [1]

[23]	Xiao L, Zhou J, Tan W, et al. Contrast-enhanced US with perfluorobutane to diagnose small lateral cervical lymph node metastases of papillary thyroid carcinoma[J]. Radiology, 2023, 307(4):e221465.DOI:10.1148/radiol.221465. Cited in this article [1]

[24]	Wei Y, Niu Y, Zhao ZL, et al. Effectiveness of lymphatic contrast enhanced ultrasound in the diagnosis of cervical lymph node metastasis from papillary thyroid carcinoma[J]. Sci Rep, 2022, 12(1):578.DOI:10.1038/s41598-021-04503-1. Cited in this article [2]

[25]	Zhang Y, Lu YY, Li W, et al. Lymphatic contrast-enhanced US to improve the diagnosis of cervical lymph node metastasis from thyroid cancer[J]. Radiology, 2023, 307(4):e221265.DOI:10.1148/radiol.221265. Cited in this article [1]

[26]	张艳, 马冰, 赵佳航, 等. 经淋巴管超声造影诊断甲状腺癌颈部淋巴结转移的价值[J]. 中国医学科学院学报, 2021, 43(3):338-342.DOI:10.3881/j.issn.1000-503X.13891. Cited in this article [1]

[27]	张艳, 赵佳航, 王冰, 等. 经淋巴管超声造影可提高甲状腺癌中央区转移淋巴结的检出率[J]. 南方医科大学学报, 2023, 43(2):219-224.DOI:10.12122/j.issn.1673-4254.2023.02.09. Cited in this article [1]

[28]	王平云, 杨贺庆, 葛昆朋. 纳米碳示踪技术与超声造影术对甲状腺癌手术患者近期结局的影响[J]. 中华生物医学工程杂志, 2022, 28(1):43-48.DOI:10.3760/cma.j.cn115668-20210713-00168. Cited in this article [1]